跳至主要内容
临床试验/EUCTR2010-024001-12-FI
EUCTR2010-024001-12-FI进行中(未招募)1 期

The effect of bevacizumab treatment on reading ability in age related macular degeneration - Reading after bevacizumab treatment in AMD

TYKS0 个研究点目标入组 50 人开始时间: 2010年12月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Patients from the Department of Ophthalmology, Turku University Hospital, which have wet form of age related macular degeneration of the eye and are decided to be treated with intravitreal bevacizumab according to hospitals routine clinical guidelines.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • No other eye diseases

研究者

发起方
TYKS

相似试验

The effect of bevacizumab treatment on reading... | 临床试验